1887

Abstract

Summary

Sera from 20 cystic fibrosis patients, whose lungs were colonised by , were examined in a 3–5-year prospective study for any relationship between IgG subclass antibody levels to a- and b-type flagellins and pulmonary function (FEV and radiological score). Patients were divided into two groups according to their pulmonary status: Group 1 comprised 11 patients with poor pulmonary status; group 2 comprised nine patients with relatively good pulmonary status. High concentrations of IgG1, IgG2 and IgG3 antibodies to flagellins, particularly to the b-type, were found in most patients. IgG4 reactivity was observed in only a few patients. Comparison of the two groups of patients showed that those with poor pulmonary status (group 1) had a significantly higher concentration (p ≪ 0.05) of IgG3 for two of the three periods studied and of IgG2 for the last period studied. Moreover, IgG3 and IgG1 reactivities to b-type flagellin and IgG3 to a-type flagellin were also increased significantly (p ≪ 0.05) in group 1 patients between the first and the last period studied. These patients also showed a significant (p ≪ 0.05) time-dependent increase in IgG3 and IgG1 antibody concentrations. These data demonstrate that cystic fibrosis patients with poorer pulmonary status have higher IgG3 levels to flagellin than other cystic fibrosis patients. High concentrations of strong opsonic IgG3 and, to a lesser degree, of IgG1 antibodies may increase pulmonary inflammation and induce heightened pulmonary deterioration.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-43-4-270
1995-10-01
2024-03-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/43/4/medmicro-43-4-270.html?itemId=/content/journal/jmm/10.1099/00222615-43-4-270&mimeType=html&fmt=ahah

References

  1. Bodey G. P., Bolivar R., Fainstein V., Jadeja L. Infections caused by Pseudomonas aeruginosa. Rev Infect Dis 1983; 5:279–313
    [Google Scholar]
  2. Gilligan P. H. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 1991; 4:35–51
    [Google Scholar]
  3. Schiøtz P. O. Systemic and mucosal immunity and non-specific defense mechanisms in cystic fibrosis patients. Acta Pediatr Scand 1982; 301: (Suppl) 55–62
    [Google Scholar]
  4. Høiby N. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. Acta Pathol Microbiol Scand (Suppl) 1977; 262:1–96
    [Google Scholar]
  5. Dӧring G. Høiby N. Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis. Infect Immun 1983; 42:197–201
    [Google Scholar]
  6. Lagacé J., Mercier J., Fréchette M. Circulating immune complexes, antibodies to Pseudomonas aeruginosa, and pulmonary status in cystic fibrosis. J Clin Lab Immunol 1989; 30:7–11
    [Google Scholar]
  7. Likavcanova E., Lagacé J. Quantitative analysis of immuno globulin G subclass responses to Pseudomonas aeruginosa antigens in cystic fibrosis. J Med Microbiol 1992; 36:437–444
    [Google Scholar]
  8. Hodson M. E., Morris L., Batten J. C. Serum immunoglobulins and immunoglobulin G subclasses in cystic fibrosis related to the clinical state of the patient. Eur Respir J 1988; 1:701–705
    [Google Scholar]
  9. Pressler T., Pedersen S. S., Espersen F., Høiby N., Koch C. IgG subclass antibody responses to alginate from Pseudomonas aeruginosa in patients with cystic fibrosis and chronic P. aeruginosa infection. Pediatr Pulmonol 1992; 14:44–51
    [Google Scholar]
  10. Cowan R. G., Winnie G. B. Anti-Pseudomonas aeruginosa IgG subclass titers in patients with cystic fibrosis: correlations with pulmonary function, neutrophil chemotaxis, and phagocytosis. J Clin Immunol 1993; 13:359–370
    [Google Scholar]
  11. Drake D., Montie T. C. Flagella, motility, and invasive virulence of Pseudomonas aeruginosa. J Gen Microbiol 1988; 134:43–52
    [Google Scholar]
  12. Drake D., Montie T. C. Protection against Pseudomonas aeru ginosa infection by passive transfer of anti-flagellar serum. Can J Microbiol 1987; 33:755–763
    [Google Scholar]
  13. Allison J. S., Dawson M., Drake D., Montie T. C. Electrophoretic separation and molecular weight characterization of Pseudomonas aeruginosa H-antigen flagellins. Infect Immun 1985; 49:770–774
    [Google Scholar]
  14. Montie T. C., Anderson T. R. Enzyme-linked immunosorbent assay for detection of Pseudomonas aeruginosa H (flagellar) antigen. Eur J Clin Microbiol Infect Dis 1988; 7:256–260
    [Google Scholar]
  15. Ansorg R. Flagellaspezifisches H-Antigenschema von Pseudomonas aeruginosa. Zentralbl Bakteriol Orig A 1978; 242:228–238
    [Google Scholar]
  16. Crowe B. A., Enzersberger O., Schober-Bendixen S. The first clinical trial of immuno’s experimental Pseudomonas aeruginosa flagellar vaccines. Antibiot Chemother 1991; 44:143–56
    [Google Scholar]
  17. Anderson T. R., Montie T. C., Murphy M. D., McCarthy V. P. Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis. J Clin Microbiol 1989; 27:2789–2793
    [Google Scholar]
  18. Brasfield D., Hicks G., Soong S.-J., Peters J., Tiller R. Evaluation of scoring system of the chest radiograph in cystic fibrosis: a collaborative study. AJR 1980; 134:1195–1198
    [Google Scholar]
  19. Montie T. C., Craven R. C., Holder I. A. Flagellar preparations from Pseudomonas aeruginosa: isolation and characterization. Infect Immun 1982; 35:281–288
    [Google Scholar]
  20. Kelly-Wintenberg K., Anderson T., Montie T. C. Phosphorylated tyrosine in the flagellum filament protein of Pseudomonas aeruginosa. J Bacteriol 1990; 172:5135–5139
    [Google Scholar]
  21. Nutman T. B., Withers A. S., Ottesen E. A. In vitro parasite antigen-induced antibody responses in human helminth infections. J Immunol 1985; 135:2794–2799
    [Google Scholar]
  22. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 111:680–685
    [Google Scholar]
  23. Morrissey J. H. Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem 1981; 117:307–310
    [Google Scholar]
  24. Towbin H., Gordon J. Immunoblotting and dot immuno-binding-current status and outlook. J Immunol Methods 1984; 72:313–340
    [Google Scholar]
  25. Hamilton R. G. Human IgG subclass measurements in the clinical laboratory. Clin Chem 1987; 33:1707–1725
    [Google Scholar]
  26. Luzar M. A., Thomassen M. J., Montie T. C. Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition. Infect Immun 1985; 50:577–582
    [Google Scholar]
  27. Hammarstrӧm L., Smith C. I. E. IgG subclasses in bacterial infections. Monogr Allergy 1986; 19:122–123
    [Google Scholar]
  28. Albus A., Saalmann M., Tesch H., Pedersen S. S., Dӧring G. Increased levels of IgG subclasses specific for Pseudomonas aeruginosa exoenzyme and polysaccharide antigens in chronically infected patients with cystic fibrosis. APMIS 1989; 97:1146–1148
    [Google Scholar]
  29. Augener W., Grey H. M., Cooper N. R., Muller-Eberhard H. J. The reaction of monomeric and aggregated immunoglobulins with C1. Immunochemistry 1971; 8:1011–1020
    [Google Scholar]
  30. Fick R. B., Naegel G. P., Squier S. U., Wood R. E., Gee J. B. L., Reynolds H. Y. Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis. J Clin Invest 1984; 74:236–248
    [Google Scholar]
  31. Tosi M. F., Zakem H., Berger M. Neutrophil elastase cleaves C3bi on opsonized Pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. J Clin Invest 1990; 86:300–308
    [Google Scholar]
  32. Lam J., Chan R., Lam K., Costerton J. W. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun 1980; 28:546–556
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-43-4-270
Loading
/content/journal/jmm/10.1099/00222615-43-4-270
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error